Cepheid
This article was originally published in Start Up
Executive Summary
Miniaturization & microfluidics. Cepheid's mission is to reduce the size of key diagnostic instrument components and then design fully-integrated, miniaturized, bioanalytical test systems. The company's initial focus is a miniaturized device for the polymerase chain reaction(PCR).
You may also be interested in...
Miniaturization & Microfluidics
Venture capitalists have been pouring money into start-up companies who promise to shrink, speed, and reduce the cost of any and all bioanalytical processes. Their target markets are drug screening, where throughput is prized; and diagnostics, where miniaturization brings portability and opportunities in point-of-care testing.
The People Business: The Renaissance of Population Genetics
New technologies enable the rapid processing of genetic information, but since gene data isn't associated with specific diseases and diseased tissues, in and of itself it isn't clinically useful. A new breed of start-ups aims to provide both the phenotypic and genotypic sides of the equation by creating databases of patients and patient samples. Still unclear is how much drug firms will pay for disease-associated gene data; genetics firms are taking various approaches to monetizing their databases, from focusing initially on high-value diagnostics to creating true target-discovery businesses, to selling their data along with associated software and services. There are also ethical issues to hammer out. The new companies must take care to protect patients' rights. They must consider the need for explicit consent to use the information collected from patients, especially when they are participating in research whose purpose is as yet undefined.
Re-Engineering Drug Development II: Clinical Data Collection & Management
Despite a history of failed products, start-up companies are looking to reinvent how data from clinical trials is collected and managed. Firms are trying to replace the point solutions of the past with broad software offerings that can take clients from "site to submission."